Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markman

Showing results (421-430 of 1,623) with videos related to

Pageof 163
Sort By:
Clinical Advances in Hematology & Oncology : H&O|October 15, 2005
Rationale for maintenance or consolidation therapy in ovarian cancerMaurie Markman
Gynecologic Oncology|October 18, 2005
Viewing ovarian cancer as a "chronic disease": what exactly does this mean?Maurie Markman
CA: a Cancer Journal for Clinicians|November 1, 1986
The ethical dilemma of phase I clinical trialsM Markman
Oncology|May 24, 2014
External beam radiation with 'curative intent' in advanced ovarian cancer: an uncommon but rational management approach based on the natural history of cancer in an individual patientMaurie Markman
Current Oncology Reports|April 14, 2007
Use of progression-free survival as a valid endpoint in phase II cancer clinical trialsMaurie Markman
Current Oncology Reports|October 22, 2008
Predictive value of neoadjuvant chemotherapy for the clinical utility of subsequently performed major cancer surgeryMaurie Markman
Current Oncology Reports|November 10, 2007
Diagnostic dilemmas in cancer medicine: focusing on the treatableMaurie Markman
Gynecologic Oncology|January 3, 2007
Re: "En bloc resection of diaphragm with lung for recurrent ovarian cancer: a case report"Maurie Markman
Oncology|March 10, 2007
Presentations of phase 2 clinical trial abstracts at a national oncology meeting: potential implications for subsequent publication in the peer-reviewed literatureMaurie Markman
Current Oncology Reports|August 21, 2007
Recognizing the toxicity of "nontoxic" drugs employed in the management of malignant diseaseMaurie Markman
Pageof 163

Showing results (421-430 of 1,623) with videos related to

Sort By:
Pageof 163
Clinical Advances in Hematology & Oncology : H&O|October 15, 2005
Rationale for maintenance or consolidation therapy in ovarian cancerMaurie Markman
Gynecologic Oncology|October 18, 2005
Viewing ovarian cancer as a "chronic disease": what exactly does this mean?Maurie Markman
CA: a Cancer Journal for Clinicians|November 1, 1986
The ethical dilemma of phase I clinical trialsM Markman
Oncology|May 24, 2014
External beam radiation with 'curative intent' in advanced ovarian cancer: an uncommon but rational management approach based on the natural history of cancer in an individual patientMaurie Markman
Current Oncology Reports|April 14, 2007
Use of progression-free survival as a valid endpoint in phase II cancer clinical trialsMaurie Markman
Current Oncology Reports|October 22, 2008
Predictive value of neoadjuvant chemotherapy for the clinical utility of subsequently performed major cancer surgeryMaurie Markman
Current Oncology Reports|November 10, 2007
Diagnostic dilemmas in cancer medicine: focusing on the treatableMaurie Markman
Gynecologic Oncology|January 3, 2007
Re: "En bloc resection of diaphragm with lung for recurrent ovarian cancer: a case report"Maurie Markman
Oncology|March 10, 2007
Presentations of phase 2 clinical trial abstracts at a national oncology meeting: potential implications for subsequent publication in the peer-reviewed literatureMaurie Markman
Current Oncology Reports|August 21, 2007
Recognizing the toxicity of "nontoxic" drugs employed in the management of malignant diseaseMaurie Markman
Pageof 163